Aytu Biopharma Inc
F:AY20
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aytu Biopharma Inc
F:AY20
|
US |
|
A
|
AQ Group AB
STO:AQ
|
SE |
|
J
|
Jabil Inc
XMUN:JBL
|
US |
Wall St Price Targets
AY20 Price Targets Summary
Aytu Biopharma Inc
According to Wall Street analysts, the average 1-year price target for AY20 is 13.322 EUR with a low forecast of 9.72 EUR and a high forecast of 20.932 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AY20's stock price target?
Price Target
13.322
EUR
According to Wall Street analysts, the average 1-year price target for AY20 is 13.322 EUR with a low forecast of 9.72 EUR and a high forecast of 20.932 EUR.
What is the Revenue forecast for Aytu Biopharma Inc?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Aytu Biopharma Inc?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 45%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Aytu Biopharma Inc?
Projected CAGR
78%
The compound annual growth rate for Operating Income over the next 3 years is 78%.
